Verbel DA - Search Results

1

Two-stage designs for gene-disease association studies.

Satagopan JM, Verbel DA, Venkatraman ES, Offit KE, Begg CB. Satagopan JM, et al. Among authors: verbel da. Biometrics. 2002 Mar;58(1):163-70. doi: 10.1111/j.0006-341x.2002.00163.x. Biometrics. 2002. PMID: 11890312 Free PMC article.

2

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.

Maluf FC, Cordon-Cardo C, Verbel DA, Satagopan JM, Boyle MG, Herr H, Bajorin DF. Maluf FC, et al. Among authors: verbel da. Ann Oncol. 2006 Nov;17(11):1677-86. doi: 10.1093/annonc/mdl289. Epub 2006 Sep 19. Ann Oncol. 2006. PMID: 16984978 Free article.

3

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.

Hamlin PA, Zelenetz AD, Kewalramani T, Qin J, Satagopan JM, Verbel D, Noy A, Portlock CS, Straus DJ, Yahalom J, Nimer SD, Moskowitz CH. Hamlin PA, et al. Blood. 2003 Sep 15;102(6):1989-96. doi: 10.1182/blood-2002-12-3837. Epub 2003 Apr 3. Blood. 2003. PMID: 12676776 Free article. Clinical Trial.

4

Quantifying the amount of variation in survival explained by prostate-specific antigen.

Verbel DA, Heller G, Kelly WK, Scher HI. Verbel DA, et al. Clin Cancer Res. 2002 Aug;8(8):2576-9. Clin Cancer Res. 2002. PMID: 12171886

5

Loss of p63 expression is associated with tumor progression in bladder cancer.

Urist MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, Ince TA, McKeon FD, Cordon-Cardo C. Urist MJ, et al. Am J Pathol. 2002 Oct;161(4):1199-206. doi: 10.1016/S0002-9440(10)64396-9. Am J Pathol. 2002. PMID: 12368193 Free PMC article.

6

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP. Gurrieri C, et al. Among authors: verbel da. J Natl Cancer Inst. 2004 Feb 18;96(4):269-79. doi: 10.1093/jnci/djh043. J Natl Cancer Inst. 2004. PMID: 14970276

7

p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.

Puig P, Capodieci P, Drobnjak M, Verbel D, Prives C, Cordon-Cardo C, Di Como CJ. Puig P, et al. Clin Cancer Res. 2003 Nov 15;9(15):5642-51. Clin Cancer Res. 2003. PMID: 14654547

8

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer.

Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, Ross JS, Cordon-Cardo C. Osman I, et al. Clin Cancer Res. 2001 Sep;7(9):2643-7. Clin Cancer Res. 2001. PMID: 11555574

9

Improved prediction of prostate cancer recurrence through systems pathology.

Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, Reuter VE, Scher HI, Kattan MW, Bianco FJ, Wheeler TM, Ayala GE, Scardino PT, Donovan MJ. Cordon-Cardo C, et al. Among authors: verbel da. J Clin Invest. 2007 Jul;117(7):1876-83. doi: 10.1172/JCI31399. J Clin Invest. 2007. PMID: 17557117 Free PMC article.

10

17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.

Solit DB, Zheng FF, Drobnjak M, Münster PN, Higgins B, Verbel D, Heller G, Tong W, Cordon-Cardo C, Agus DB, Scher HI, Rosen N. Solit DB, et al. Clin Cancer Res. 2002 May;8(5):986-93. Clin Cancer Res. 2002. PMID: 12006510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page